Matches in Wikidata for { <http://www.wikidata.org/entity/Q90447726> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q90447726 description "article scientifique publié en 2019" @default.
- Q90447726 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90447726 description "scientific article published on 09 January 2019" @default.
- Q90447726 description "wetenschappelijk artikel" @default.
- Q90447726 description "наукова стаття, опублікована 9 січня 2019" @default.
- Q90447726 name "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 name "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 type Item @default.
- Q90447726 label "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 label "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 prefLabel "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 prefLabel "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 P1433 Q90447726-634FED3C-CD7B-49A8-BB58-C35E675D3064 @default.
- Q90447726 P1476 Q90447726-F6E7523C-B0E2-4A02-A192-0E7D1C82374D @default.
- Q90447726 P2093 Q90447726-58C01528-A2EF-480C-963A-27C18C5ECD70 @default.
- Q90447726 P2093 Q90447726-6A8CEB4E-2777-432E-B481-056584023240 @default.
- Q90447726 P2093 Q90447726-7FCF89C5-1924-40D0-BBFD-FCDCCB317225 @default.
- Q90447726 P2093 Q90447726-AC431232-C6B4-4D0C-9E20-A59402D1FF57 @default.
- Q90447726 P2093 Q90447726-E22D8FB7-0CAF-4898-A012-D086AAF39888 @default.
- Q90447726 P304 Q90447726-AD022726-F400-40CE-9796-1F54E8A00E33 @default.
- Q90447726 P31 Q90447726-B52BF4F1-4A9C-45D9-8395-C638D4B488CF @default.
- Q90447726 P356 Q90447726-1552D562-E44B-4A08-8E91-637B38E4375A @default.
- Q90447726 P433 Q90447726-98AE2699-B5C5-4B83-9C76-35FE508E7DA1 @default.
- Q90447726 P478 Q90447726-5CF7C730-E014-4F5E-80B2-6DED2F173292 @default.
- Q90447726 P50 Q90447726-117673CA-CE15-48FC-BE11-E317C8DA3508 @default.
- Q90447726 P50 Q90447726-4E1E71DB-4FCC-4AA2-BD67-C52065F6DA27 @default.
- Q90447726 P50 Q90447726-EDC9A36C-D5BA-48C0-AA53-5E849BCBB06C @default.
- Q90447726 P577 Q90447726-D8D07BF1-D4B2-4119-A000-270BD89D1691 @default.
- Q90447726 P698 Q90447726-F8880806-2560-4E42-AF41-F4DCC84BDF0C @default.
- Q90447726 P356 ACS.JMEDCHEM.8B01609 @default.
- Q90447726 P698 30543421 @default.
- Q90447726 P1433 Q900316 @default.
- Q90447726 P1476 "Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation" @default.
- Q90447726 P2093 "Giovanni Tangherlini" @default.
- Q90447726 P2093 "Karin Loser" @default.
- Q90447726 P2093 "Nadine Mykicki" @default.
- Q90447726 P2093 "Sonja Ständer" @default.
- Q90447726 P2093 "Tao Che" @default.
- Q90447726 P304 "893-907" @default.
- Q90447726 P31 Q13442814 @default.
- Q90447726 P356 "10.1021/ACS.JMEDCHEM.8B01609" @default.
- Q90447726 P433 "2" @default.
- Q90447726 P478 "62" @default.
- Q90447726 P50 Q64169252 @default.
- Q90447726 P50 Q88011614 @default.
- Q90447726 P50 Q88470959 @default.
- Q90447726 P577 "2019-01-09T00:00:00Z" @default.
- Q90447726 P698 "30543421" @default.